PRN: Global LASIK Surgery Market - Analysis, Technologies & Forecasts to 2021 - Key Vendors are Johnson & Johnson, Novartis, Valeant Pharmaceuticals, Carl Zeiss & Nidek

11/ago/2017 00:00:09 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Global LASIK Surgery Market - Analysis, Technologies & Forecasts to 2021 - Key Vendors are Johnson & Johnson, Novartis, Valeant Pharmaceuticals, Carl Zeiss & Nidek


DUBLIN, August 10, 2017 /PRNewswire/ --

The "Global LASIK Surgery Market 2017-2021" report has been added to Research and Markets' offering.

Research and Markets Logo

The global LASIK surgery market to grow at a CAGR of 5.63% during the period 2017-2021.

Global LASIK Surgery Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

One trend in the market is increasing medical tourism for LASIK surgery. A LASIK surgery is an expensive procedure (costs approximately $2000) and is not covered by most medical insurance companies. Due to the high costs, many patients, especially from the US, are getting their LASIK surgeries done in countries that provide LASIK surgeries at significantly lower rates such as India, Spain, Thailand, Mexico, and the UAE.

According to the report, one driver in the market is increasing awareness about LASIK surgery. The awareness about the benefits of LASIK is increasing worldwide. Many companies, organizations, and eye clinics are taking initiatives to increase awareness about the benefits of LASIK procedures in social media and other advertising mediums. LASIK laser eye surgeries are comparatively popular than the alternative forms of laser eye surgeries like laser-assisted subepithelial keratectomy (LASEK). LASIK surgeries have faster recovery time, higher precision, and can correct a wider range of eye prescriptions.

Further, the report states that one challenge in the market is minimal insurance coverage. Like other vision care procedures, eye surgery is an expensive procedure and primarily an out-of pocket expense. As a result, consumers may not opt for corrective eye surgery when they have low discretionary income. An average LASIK surgery costs around $2000, per eye. Most insurance companies such as UnitedHealthcare and Cigna don't provide reimbursements for LASIK eye surgery as it is considered to be an elective or cosmetic surgery. The vast majority of the general population cannot afford LASIK surgeries.

Key Vendors

  • Johnson & Johnson
  • Novartis
  • Valeant Pharmaceuticals International
  • Carl Zeiss
  • Nidek

Other Prominent Vendors

  • Ziemer Ophthalmic Systems
  • LaserSight Technologies

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

PART 05: Market landscape

PART 06: Market segmentation by technology

PART 07: Market segmentation by end-user

PART 08: Geographical segmentation

PART 09: Decision framework

PART 10: Drivers and challenges

PART 11: Market trends

PART 12: Vendor landscape

PART 13: Key vendor analysis

For more information about this report visit

Media Contact:

Research and Markets
Laura Wood, Senior Manager  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

blog comments powered by Disqus è un servizio offerto da Factotum Srl